Cepacol
- Product NDC
- 63824-744
- 11-digit product format
- 638240744
- Labeler code
- 63824
- Product ID
- 63824-744_51b5d087-def6-54b3-e063-6294a90ac9ad
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- BENZOCAINE and DEXTROMETHORPHAN HYDROBROMIDE
- Dosage form
- LOZENGE
- Route
- ORAL
- Labeler
- Reckitt Benckiser LLC
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2014-05-05
- Substance
- DEXTROMETHORPHAN HYDROBROMIDE; BENZOCAINE
- Active strength
- 5; 7.5 mg/1; mg/1
- Pharmacologic classes
- Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Standardized Chemical Allergen [EPC], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 63824-744 | 63824-744-36 | D | Discontinued by firm | 2026-10-16 | |
| excluded package | package | 63824-744 | 63824-744-94 | D | Discontinued by firm | 2026-10-16 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 63824-744-94 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 63824-744-36 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 63824-744-94 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 63824-744-36 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 63824-744-36 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 63824-744-94 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 63824-744-36 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 63824-744-94 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 63824-744-36 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 63824-744-94 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 63824-744-94 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 63824-744-36 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 63824-744-94 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 63824-744-36 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 63824-744-94 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 63824-744-36 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 63824-744-94 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 63824-744-36 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 63824-744-94 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 63824-744-36 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 63824-744-94 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 63824-744-36 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 63824-744-94 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 63824-744-36 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cepacol
- Brand name suffix
- Extra Strength Sore Throat and Cough
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DEXTROMETHORPHAN HYDROBROMIDE | 5 mg/1 |
| BENZOCAINE | 7.5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9D2RTI9KYH | Internal UNII lookup |
| U3RSY48JW5 | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| c0cc32db-90f0-4106-8538-89821083ece1 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fb7ab793-2c12-4079-b100-a64f73bef25a | Product name | 4 | 20240712 |
| b0cbf770-6cc3-4aa4-9158-755110c2b9f7 | Product name | 2 | 20230717 |
| dc7c5daa-021f-40dd-b00d-63982cb2067a | Product name | 1 | 20230426 |
| 08ffbcbf-26df-b99c-1dab-64fc4cfae89f | Product name | 5 | 20200925 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 419aab54-5d5a-4146-9453-026d4a9991be | Product name | 2 | 20170525 |
| 08ffbcbf-26df-b99c-1dab-64fc4cfae89f | Product name | 2 | 20160823 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63824-744-16 | CepacolExtra Strength Sore Throat and Cough | 8 in 1 BLISTER PACK | LOZENGE | 8 | 14 | |
| 63824-744-16 | CepacolExtra Strength Sore Throat and Cough | 2 in 1 CARTON | LOZENGE | 2 | 14 | |
| 63824-744-36 | CepacolExtra Strength Sore Throat and Cough | 3 in 1 CARTON | LOZENGE | 3 | 14 | |
| 63824-744-36 | CepacolExtra Strength Sore Throat and Cough | 12 in 1 BLISTER PACK | LOZENGE | 12 | 14 | |
| 63824-744-94 | CepacolExtra Strength Sore Throat and Cough | 4 in 1 BLISTER PACK | LOZENGE | 4 | 14 | |
| 63824-744-94 | CepacolExtra Strength Sore Throat and Cough | 1 in 1 CARTON | LOZENGE | 1 | 14 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63824-744-16 | EA - Each | 63824-744 | 7cd08d15-6f23-4040-a102-e5213cd34025 | 1 | 2019-03-12 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63824-744 | CEPACOL EXTRA STRENGTH SORE THROAT AND COUGH (BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE) LOZENGE [RB HEALTH (US) LLC] | 10 | Current NDC, Legacy NDC, 6 package rows | 20250323_c0cc32db-90f0-4106-8538-89821083ece1.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TRIPROLIDINE HYDROCHLORIDE | TRIPROLIDINE HYDROCHLORIDE | Westminster Pharmaceuticals, LLC | 4eeffb6d-fc5e-48bc-95f6-ec4d5cb6e0d2 | 2026-08-10 | Warnings | M012 |
| TRIPROLIDINE HYDROCHLORIDE | TRIPROLIDINE HYDROCHLORIDE | Westminster Pharmaceuticals, LLC | a9f01760-e335-4410-a9b8-8edce2841270 | 2026-08-10 | Warnings | M012 |
| Guaifed | GUAIFENESIN | Aldama Pharmaceuticals, Inc | 38f37272-2084-a33b-e063-6294a90ac150 | 2026-08-10 | Warnings | M012 |
| Chlorpheniramine Maleate | CHLORPHENIRAMINE MALEATE | PD-Rx Pharmaceuticals, Inc. | 7a3452a2-930f-48b1-8c59-dbceb10b9c78 | 2026-08-10 | Warnings | M012 |
| Guaifed DM | DEXTROMETHORPHAN, GUAIFENESIN | Aldama Pharmaceuticals, Inc | 396bf716-0f61-9563-e063-6394a90a171b | 2026-08-10 | Warnings | M012 |
| Daytime Cold and Flu mini Softgels | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | Shield Pharmaceuticals Corp | eff114fe-fb15-48dd-b673-4d4d66406e69 | 2026-08-10 | Warnings | M012 |
| Sleep Aid | DIPHENHYDRAMINE HCL | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 651b03a3-b85e-4028-a9f2-472bec16c8f4 | 2026-08-10 | Warnings | M012 |
| NASAL | PHENYLEPHRINE HYDROCHLORIDE | Amazon.com Services LLC | 02a89765-2a75-470a-9fd6-8cce71dc19e9 | 2026-08-10 | Warnings | M012 |
| WINCO Maximum StrengthCold Flu and Sore Throat | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | WINCO FOODS, LLC | f34bfb71-2c81-44d0-a2a0-4d320c43c217 | 2026-08-07 | Warnings | M012 |
| DAYTIME NIGHTTIME ELDERBERRY COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | Walgreen Company | 11cac20e-9bb6-4e2d-8efd-4451f055c7b4 | 2026-08-07 | Warnings | M012 |
| Winco Foods Childrens Multi Symptom Cold | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | WINCO FOODS, LLC | 1d02b32a-e88d-4c70-b66d-7bdc22c25a43 | 2026-08-07 | Warnings | M012 |
| foster and thrive daytime cold and flu relief nighttime cold and flu relief | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Strategic Sourcing Services LLC | c1ecc56b-8052-4b0a-900a-dc93a24771bd | 2026-08-07 | Warnings | M012 |
| Adult Long Lasting Cough Relief | DEXTROMETHORPHAN HBR | Shield Pharmaceuticals Corp | bbf7d296-fa3d-43e5-984c-e9d2881a074d | 2026-08-07 | Warnings | M012 |
| Severe Cold and Cough Daytime | ACETAMINOPHEN, DEXTROMETHORPHAN, PHENYLEPHRINE | WinCo Foods, LLC | 790d534a-0f40-495b-a815-67851ac3d20d | 2026-08-07 | Warnings | M012 |
| Extra Moisturizing Nasal Pump Mist Anti Drip | OXYMETAZOLINE HYDROCHLORIDE | WinCo FOODS, LLC | 46ebd262-c6a4-43ea-a7f6-506561bb3de4 | 2026-08-07 | Warnings | M012 |
| Mucus Relief DM Maximum Strength | DEXTROMETHORPHAN HBR AND GUAIFENESIN | WINCO FOODS, LLC | e6afa830-6ce2-4abc-b5c9-3f5f156444df | 2026-08-07 | Warnings | M012 |
| Sinus PE Pressure plus Pain MAXIMUM STRENGTH | ACETAMINOPHEN, PHENYLEPHRINE HCL | CVS Pharmacy | a3b073b4-494c-4531-b08e-475c86ba321d | 2026-08-07 | Warnings | M012 |
| Severe Cold and Cough Nighttime | ACETAMINOPHEN, DIPHENHYDRAMINE, PHENYLEPHRINE | WinCo Foods, LLC | dc56197c-c108-4b35-b791-dde5c3384ddd | 2026-08-07 | Warnings | M012 |
| Sinus Severe Non Drowsy, Daytime | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL | Meijer Distribution, Inc. | 84c30ec9-a7b5-4d2f-95b2-d6fb895945de | 2026-08-07 | Warnings | M012 |
| Diphenhydramine Hydrochloride | DIPHENHYDRAMINE HYDROCHLORIDE | Cardinal Health 107, LLC | 887cabe5-46d0-4f4e-8f5a-2cfdbc157b58 | 2026-08-07 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1039255 | Cepacol Sore Throat Plus Cough 7.5 MG / 5 MG Oral Lozenge | PSN | c0cc32db-90f0-4106-8538-89821083ece1 | 14 |
| 1039251 | dextromethorphan HBr 5 MG / benzocaine 7.5 MG Oral Lozenge | PSN | c0cc32db-90f0-4106-8538-89821083ece1 | 14 |
| 1039255 | benzocaine 7.5 MG / dextromethorphan hydrobromide 5 MG Oral Lozenge [Cepacol Sore Throat Plus Cough] | SBD | c0cc32db-90f0-4106-8538-89821083ece1 | 14 |
| 1039251 | benzocaine 7.5 MG / dextromethorphan hydrobromide 5 MG Oral Lozenge | SCD | c0cc32db-90f0-4106-8538-89821083ece1 | 14 |
| 1039255 | Cepacol Sore Throat Plus Cough (benzocaine 7.5 MG / dextromethorphan hydrobromide 5 MG) Oral Lozenge | SY | c0cc32db-90f0-4106-8538-89821083ece1 | 14 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63824-744-16 | 63824074416 | 2 BLISTER PACK in 1 CARTON (63824-744-16) / 8 LOZENGE in 1 BLISTER PACK | 2 blister pack | 2014-05-05 | 0000-00-00 | No | No | Current |
| 63824-744-36 | 63824074436 | 3 BLISTER PACK in 1 CARTON (63824-744-36) > 12 LOZENGE in 1 BLISTER PACK | 3 blister pack | 2019-05-01 | 0000-00-00 | No | No | Current |
| 63824-744-94 | 63824074494 | 1 BLISTER PACK in 1 CARTON (63824-744-94) > 4 LOZENGE in 1 BLISTER PACK | 1 blister pack | 2014-05-05 | 0000-00-00 | No | No | Current |